Reactive arthritis: how to identify and respond

Reactive arthritis is a specific form of joint inflammation, often unexpected and sometimes difficult to identify. Occurring after an infection elsewhere in the body, this condition primarily affects young adults, often those actively engaged in professional and family life. Accurate symptom recognition and prompt action are crucial in limiting complications. Indeed, although this form of arthritis is not directly contagious, it requires vigilance and monitoring to minimize its impact on quality of life. By 2025, with advances in medical knowledge and diagnostic tools like ArthriDétect, it will be possible to improve patient care while providing patients with a better understanding of the underlying mechanisms and appropriate prevention strategies.

What is reactive arthritis: understanding a complex and multifactorial disease? Reactive arthritis, formerly known as Reiter’s syndrome, is an inflammation that affects not only the joints, but also the tendons and sometimes other organs. It manifests after an infection, often digestive or urogenital; however, the microbes responsible are not found in the joints themselves. It is a disproportionate immune response that triggers an inflammatory reaction targeting the joints, primarily those of the knees, spine, and sacroiliac joints. This inflammatory reaction can generate intense pain, stiffness, swelling, and limit movement.

The disease primarily affects men between the ages of 20 and 40, a period of life when mobility is essential. Among the factors that contribute to this condition, genetic predisposition plays a significant role. The presence of the HLA-B27 antigen, found in a large proportion of patients, increases the risk. This genetic association may involve an exacerbated immune response to certain microorganisms, particularly bacteria such as Chlamydia trachomatis, responsible for many silent but inflammatory urogenital infections. Furthermore, other bacteria such as Ureoplasma urealyticum are also implicated, as are intestinal bacteria (Salmonella, Shigella, Campylobacter, or Yersinia). Sometimes, even intestinal parasites or certain vaccinations can trigger this reaction. The precise mechanism is still being studied, but it appears that the inflammatory reaction results from a complex interaction between the body and these infectious agents, with, in some individuals, a prolonged persistence of the immune response. Post-infectious inflammatory reaction

without direct joint infection Genetic factors: presence of HLA-B27 Multiple infectious agents: urogenital, digestive, parasitic

Primarily affected population: young adult men Identifying these elements is a key step that allows for accurate diagnosis and appropriate management using modern tools such as Diag’Arthrite and SignalArticulaire, which help with the early recognition of symptoms.
Recognizing the characteristic symptoms of reactive arthritis The major difficulty in managing reactive arthritis lies in the diversity and variability of its symptoms. They do not all appear at the same time and can progress through flare-ups and remissions. The first signs generally occur two to four weeks after the initial infectious episode, often long after the infection seems to have cleared.
Joint symptoms are central to the disease. These typically present as asymmetric arthritis, primarily affecting large joints such as the knees, ankles, or feet, as well as the tendon insertion points called entheses. Pain, stiffness, and sometimes swelling are present, often worsening upon waking. These symptoms make daily activities difficult, limiting overall mobility.
Extra-articular manifestations

are frequent and varied:

Eye disorders

: conjunctivitis, anterior uveitis, with eye pain and sensitivity to light Skin symptoms

: psoriasiform plaques on the palms, soles, scalp, or scrotum, sometimes accompanied by paronychia (inflammation around the nails) Mucosal lesions

: oral or genital ulcerations General symptoms
: fatigue, low-grade fever, loss of appetite Other less frequent but important symptoms to monitor include cardiac abnormalities such as myocarditis or arrhythmias, as well as renal complications, which require close clinical observation. This symptomatic variety reflects the complexity of the disease and justifies a holistic approach to evaluation.
For example, a patient presenting with joint pain and conjunctivitis following recent infectious diarrhea should immediately alert healthcare professionals so that prompt management can be considered. It is in these contexts that programs like RéagitArticulation and Alert’Articulaire prove invaluable, guiding patients in recognizing symptoms and referring them to appropriate specialists.
Symptoms often appear late after an acute infection. Pain and stiffness primarily affect large joints and entheses.

Multiple extra-articular manifestations include the eyes, skin, and mucous membranes.

Variable general symptoms can complicate diagnosis.

Diagnosis of reactive arthritis: essential methods and criteria in 2025
Diagnosis relies on careful collection of infectious history and a thorough clinical examination. The lack of specific tests necessitates the combined use of several examinations to confirm the disease and rule out other conditions, including septic arthritis and other forms of spondyloarthropathy. Diagnostic procedures include:
Biological tests: C-reactive protein and erythrocyte sedimentation rate (ESR) testing to detect inflammation, and urine tests to identify urogenital infections.
Identification of infectious agents: cultures and PCR of biological fluids to detect Chlamydia trachomatis and other associated bacteria.

Medical imaging: X-rays to visualize bone abnormalities such as irregularities in bone density, joint erosions, or enthesitis.

MRI and ultrasound: these techniques allow for precise evaluation of soft tissues, particularly detecting inflammation of tendons, ligaments, and entheses, which are often responsible for pain.

Genetic testing

The presence of HLA-B27, while not diagnostic on its own, strongly suggests reactive arthritis when accompanied by compatible symptoms.
A common example: a patient presenting with lower back pain and inflammation of the heel enthesis, combined with a positive HLA-B27 test and a history of recent genital infection, would raise suspicion of reactive arthritis. In this context, modern tools like ArthriRepère and SoutienRéactif now provide invaluable assistance in monitoring progression and adjusting treatment. By 2025, technology will also enable better personalized monitoring through symptom tracking apps and secure data sharing with healthcare professionals. This approach promotes earlier diagnosis and optimized management of reactive arthritis. Current treatments for reactive arthritis: relief and long-term action
The therapeutic approach is based primarily on managing symptoms
. Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed to reduce pain and swelling. These medications can be administered orally or sometimes injected locally, depending on the severity and location of the pain. Corticosteroids are used with caution but may be necessary in severe cases.
In addition, non-pharmacological techniques such as physiotherapy or osteopathy support joint rehabilitation, improving mobility and reducing stiffness. Rest may also be recommended to reduce the initial inflammation.

It is essential to

treat the underlying infectious cause

Underlying conditions, such as urogenital infections, require appropriate antibiotics. Simultaneous treatment of the partner(s) is recommended to prevent recurrence of the infection and thus the risk of renewed reactive arthritis.

When the disease becomes chronic or resistant to treatment, disease-modifying antirheumatic drugs (DMARDs), such as sulfasalazine, may be prescribed. Biologics targeting TNF-alpha also represent an advanced option. These therapies offer hope for controlling persistent inflammation and improving quality of life. Vigilance remains essential, as reactive arthritis can cause extra-articular complications that require ongoing monitoring. Close collaboration between the patient and healthcare professionals, combined with an innovative monitoring tool like StopArthritis, optimizes this multidisciplinary management.

Relief with anti-inflammatory drugs and corticosteroids if necessary.

Treatment of the underlying cause with appropriate antibiotics. Functional rehabilitation via physiotherapy and osteopathy. Use of DMARDs and biologics in cases of chronic progression.

Regular follow-up and monitoring for complications.

It remains essential to consult a doctor as soon as joint pain appears after an infection, in order to benefit from early diagnosis and the rapid implementation of effective treatment.

Prevention and practical advice to limit the risk of reactive arthritis.
Prevention relies primarily on reducing the risk of related infections, particularly urogenital and digestive infections. Strict hygiene, adherence to measures for the prevention of sexually transmitted infections, and appropriate medical follow-up in case of infection are essential first lines of defense.
It is also recommended to:
Consult a doctor promptly if you experience any infectious symptoms, whether digestive or genital.
Avoid self-medication and strictly adhere to prescribed treatments.

Maintain a healthy lifestyle that promotes good immunity: a balanced diet, regular physical activity, and stress management. Undergo regular checkups, especially for individuals with a history of or presence of HLA-B27.

Use digital alert and support tools: Arthrithème, Alert’Articulaire, and RéactionSanté help you stay vigilant and recognize signs early.

As a recent study shows, prevention combined with targeted information significantly reduces the incidence and severity of reactive arthritis episodes. Increased public and medical awareness is now showing positive progress. However, any persistent joint pain following an infection should prompt a consultation. The ArthriRepère strategy, which encourages this personalized follow-up, is a suitable response to this public health challenge. Therefore, paying attention to these signals and adopting preventative behavior strengthens your

Reactive Support